GPA33-SADA

N/A

Report date: 2023/04/02 12:23:05

Base Information

Drug NameGPA33-SADA
Drug Alias NameGPA33-SADA
ClassificationBiologics > Protein drugs > Immunoglobulin > AntibodyDiagnostic agent (In vivo)
Mechanisms of ActionRadionuclide imaging enhancersIonising radiation emittersAnti-GPA33
TargetsCell surface A33 antigen
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMassachusetts Institute Of TechnologyMemorial Sloan Kettering Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesMemorial Sloan Kettering Cancer CenterMassachusetts Institute Of Technology
Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A